Acknowledgement
This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (No. NRF-2022R1A2C1013518).
References
- Lee MY, Seo CS, Kim JY, Shin HK. Genotoxicity evaluation of Guibi-Tang extract using an in vitro bacterial reverse mutation assay, chromosome aberration assay, and in vivo micronucleus test. BMC Complement Altern Med. 2014;14:215. https://doi.org/10.1186/1472-6882-14-215
- Timoroglu I, Yuzbasioglu D, unal F, Yilmaz S, Aksoy H, Celik M. Assessment of the genotoxic effects of organophosphorus insecticides phorate and trichlorfon in human lymphocytes. Environ Toxicol. 2014;29(5):577-87. https://doi.org/10.1002/tox.21783
- Yuzbasioglu D, Celik M, Yilmaz S, Unal F, Aksoy H. Clastogenicity of the fungicide afugan in cultured human lymphocytes. Mutat Res. 2006;604(1-2):53-9. https://doi.org/10.1016/j.mrgentox.2006.01.001
- Rama RP, Kaul CL, Jena GB. Genotoxicity testing, a regulatory requirement for drug discovery and development: impact of ICH guidelines. Indian J Pharmacol. 2002;34(2):86-9.
- Jung C, Jung JH, Lee MS. A clinical study of immune pharmacopuncturology. Chungnam: Kyungrak Medical Publishing Co.; 2011. 523 p.
- Korean Acupuncture and Moxibustion Medicine Society. Acupuncture medicine. Seoul: Hanmi Medical Publishing Co.; 2020. 932 p.
- Sung SH, Shin BC, Park MJ, Kim KH, Kim JW, Ryu JY, et al. Current status of management on pharmacopuncture in Korea through introduction of an accreditation system. J Pharmacopuncture. 2019;22(2):75-82. https://doi.org/10.3831/KPI.2019.22.009
- Woo SH, Lee JH, Lee CI, Lee YK, Lee HJ, Kim JS. Single-dose and 4-week repeated dose toxicity of Aconitum Sinomontanum Nakai pharmacopuncture: an experimental study. J Acupunct Res. 2021;38(1):47-59. https://doi.org/10.13045/jar.2020.00332
- Ren Y, Zhang P, Yan D, Wang J, Du X, Xiao X. A strategy for the detection of quality fluctuation of a Chinese herbal injection based on chemical fingerprinting combined with biological fingerprinting. J Pharm Biomed Anal. 2011;56(2):436-42. https://doi.org/10.1016/j.jpba.2011.05.006
- Park JE. A survey on Korean medicine doctor's use of Herbal Acupuncture and recognition of its national health insurance coverage [master's thesis]. [Seoul]: Kyung Hee University; 2018. 68 p.
- Yoon JW, Kim SJ. A review of clinical study on Jungsongouhyul pharmacopuncture treatment published in Korea. J Korean Med Rehabil. 2017;27(4):75-84. https://doi.org/10.18325/jkmr.2017.27.4.75
- Kirkland D, Aardema M, Henderson L, Muller L. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity. Mutat Res. 2005;584(1-2):1-256. https://doi.org/10.1016/j.mrgentox.2005.02.004
- Ku J, Jung C, Hwang JH. Toxicological study of SU-Eohyeol Pharmacopuncture in an in vivo micronucleus test in SpragueDawley rats. Korean J Acupunct. 2022;39(2):54-62. https://doi.org/10.14406/acu.2022.008
- Ku J, Hwang JH. Genotoxicity evaluation using reversion mutation test of SU-Eohyeol pharmacopuncture. J Physiol Pathol Korean Med. 2022;36(4):113-9.
- Pessayre D, Larrey D, Biour M. Drug-induced liver injury. In: Bircher J, editor. Oxford textbook of clinical hepatology. Oxford: Oxford University Press; 1999. p. 1261-315.
- Ministry of Food and Drug Safety. Good Laboratory Practice Regulation for Nonclinical Laboratory Studies (Notification No. 2018-93) [Internet]. Cheongju: Ministry of Food and Drug Safety; 2018 Nov 21 [cited 2022 Jun 1]. Available from: https://www.law.go.kr/LSW/admRulLsInfoP.do?admRulSeq=2100000170349.
- Organization for Economic Co-operation and Development (OECD). ENV/MC/CHEM(98)17: OECD Series on Principles of Good Laboratory Practice and Compliance Monitoring Number 1 [Internet]. Paris: OECD; 1998 [cited 2022 Jun 1]. Available from: https://one.oecd.org/document/ENV/MC/CHEM(98)17/en/pdf.
- Lee DJ, Hwangbo M, Kwon K, Seo HS. Review of cervi cornu parvum pharmacopuncture in Korean medicine. J Pharmacopuncture. 2013;16(2):7-14.
- Lee YM. Introduction to evidence based medicine. J Korean Soc Vasc Surg. 2003;19(2):212-9.
- Lee B, Choi Y, Kim PW, Yang C, Lee MS. Regulation and status of herbal medicine clinical trials in Korea: a narrative review. Integr Med Res. 2021;10(2):100688. https://doi.org/10.1016/j.imr.2020.100688
- National Institute of Food and Drug Safety Evaluation (NIFDS). Herbal Medicine (Crude Drug) Formulation_Non-clinical Trial_Guideline (Complainant's Guideline) [Internet]. Cheongju: NIFDS; 2017 Sep 1 [cited 2022 Jun 1]. Available from: https://www.nifds.go.kr/brd/m_15/view.do?seq=11381&srchFr=&srchTo=&srchWord=%ED%95%9C%EC%95%BD&srchTp=0&itm_seq_1=0&itm_seq_2=0&multi_itm_seq=0&company_cd=&company_nm=&page=2.
- Kim JH, Ahn IY, Noh JY, Park SE, Yi JS, Koh KY, et al. Recent trend of international guidelines for genotoxicity testing. Regul Res Food Drug Cosmet. 2016;11(2):201-9
-
Ko YS, Yun SH, Kim MK, Song YS, Shin BC. Literatural study on toxicity of herbs used in
. Korean J Orient Physiol Pathol. 2005;19(5):1120-8. - Lee YJ, Hwang WD, Lee JW, Jeong HJ, Bae SH, Kim KG. The study of safety of herbal medicine including Fuzi(附子) on high range of LFT, RFT patients. Korean J Orient Med Prescr. 2011;19(2):179-89.
- Park YC, Park HM, Lee SD. Inducible mechanisms for hepatotoxicity caused by traditional Korean medicines in a view of toxicology. J Korean Orient Med. 2011;32(4):48-67.